These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 702306)

  • 21. Effect of low doses of heparin on the plasma binding of phenytoin and prazosin in normal man.
    Schulz P; Giacomini KM; Luttrell S; Turner-Tamiyasu K; Blaschke TF
    Eur J Clin Pharmacol; 1983; 25(2):211-4. PubMed ID: 6628503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-performance liquid chromatographic analysis and pharmacokinetics of terazosin in healthy volunteers.
    Kang BC; Yang CQ; Rhee JE; Suh OK; Shin WG
    Res Commun Mol Pathol Pharmacol; 2001; 110(5-6):371-7. PubMed ID: 12889528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prazosin dynamics in hypertension: relationship to plasma concentration.
    Seideman P; Grahnén A; Haglund K; Lindström B; von Bahr C
    Clin Pharmacol Ther; 1981 Oct; 30(4):447-54. PubMed ID: 7285478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of the antiallergenic agent, N-[4-(1H-imidazol-1-yl)butyl]-2-(1-methylethyl)-11-oxo-11H- pyrido [2,1-b]quinazoline-8-carboxamide, in plasma by reversed-phase high-performance liquid chromatographic analysis using fluorometric detection.
    Strojny N; Puglisi CV; de Silva JA
    J Chromatogr; 1984 Dec; 336(2):301-11. PubMed ID: 6530462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein binding properties of prazosin.
    Hobbs DC; Twomey TM
    Res Commun Chem Pathol Pharmacol; 1979 Jul; 25(1):189-92. PubMed ID: 451356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Densitometric determination of prazosin in plasma].
    Matousová O; Peterková M; Kakác B
    Cesk Farm; 1983 Sep; 32(7):245-6. PubMed ID: 6640681
    [No Abstract]   [Full Text] [Related]  

  • 27. Utility of Hantzsch reaction for development of highly sensitive spectrofluorimetric method for determination of alfuzosin and terazosin in bulk, dosage forms and human plasma.
    Hammad MA; Omar MA; Salman BI
    Luminescence; 2017 Sep; 32(6):1066-1071. PubMed ID: 28303653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Column-switching high-performance liquid chromatographic method for the determination of SK&F 106203 in human plasma after fluorescence derivatization with 9-anthryldiazomethane.
    Miller-Stein C; Hwang BY; Rhodes GR; Boppana VK
    J Chromatogr; 1993 Feb; 631(1-2):233-40. PubMed ID: 8450016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-performance liquid chromatographic determination of alfuzosin in biological fluids with fluorimetric detection and large-volume injection.
    Guinebault P; Broquaire M; Colafranceschi C; Thénot JP
    J Chromatogr; 1986 Feb; 353():361-9. PubMed ID: 2871035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of heparin on the red blood cell-to-plasma concentration ratio of diphenylhydantoin and prazosin.
    Schulz P; Abang A; Giacomini JC; Blaschke TF; Giacomini KM
    Ther Drug Monit; 1983; 5(4):497-9. PubMed ID: 6659020
    [No Abstract]   [Full Text] [Related]  

  • 31. A sensitive high-performance liquid chromatographic assay for the cholecystokinin-B antagonist, CI-988, in human and monkey plasma.
    Hinton JP; Jennings K; Johnson EL; Wright DS
    Biomed Chromatogr; 1995; 9(2):94-7. PubMed ID: 7795393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doxazosin determination by high-performance liquid chromatography using fluorescence detection.
    Cowlishaw MG; Sharman JR
    J Chromatogr; 1985 Nov; 344():403-7. PubMed ID: 2935549
    [No Abstract]   [Full Text] [Related]  

  • 33. Absence of effect of heparin on the binding of prazosin and phenytoin to plasma proteins.
    Giacomini KM; Giacomini JC; Blaschke TF
    Biochem Pharmacol; 1980 Dec; 29(24):3337-40. PubMed ID: 7213407
    [No Abstract]   [Full Text] [Related]  

  • 34. Ion-exchange high-performance liquid chromatography in drug assay in biological fluids. III. Propranolol, nadolol and prazosin.
    Piotrovskii VK; Belolipetskaya VG; El'man AR; Metelitsa VI
    J Chromatogr; 1983 Dec; 278(2):469-74. PubMed ID: 6668330
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative study of the relative bioavailabilities of two prazosin preparations in patients with essential hypertension].
    Rostock G; Faulhaber HD; Unger P; Homuth V; Prehm C; Günzel R
    Pharmazie; 1985 Apr; 40(4):259-61. PubMed ID: 4011659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct high-performance liquid chromatographic determination of the enantiomers of alfuzosin in plasma on a second-generation alpha 1-acid glycoprotein chiral stationary phase.
    Rouchouse A; Manoha M; Durand A; Thenot JP
    J Chromatogr; 1990 May; 506():601-10. PubMed ID: 2376608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-performance liquid chromatography-mass spectrometry method for determination of anagrelide in human plasma.
    Zhu Z; Gonthier R; Neirinck L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 822(1-2):238-43. PubMed ID: 16005692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-pressure liquid chromatographic analysis of drugs in biological fluids I. Warfarin.
    Bjornsson TD; Blaschke TF; Meffin PJ
    J Pharm Sci; 1977 Jan; 66(1):142-4. PubMed ID: 833734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atenolol determination by high-performance liquid chromatography and fluorescence detection.
    Yee YG; Rubin P; Blaschke TF
    J Chromatogr; 1979 Apr; 171():357-62. PubMed ID: 546856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitation of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in plasma by high-performance liquid chromatography.
    Young D; Evans PC; Paxton JW
    J Chromatogr; 1990 Jun; 528(2):385-94. PubMed ID: 2384576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.